As reported by a field clinical specialist (fcs), during the procedure of a 29 mm sapien 3 valve in the mitral valve via transfemoral approach, mild pvl was noted.On post-operative day (pod) 14, the patient then developed hemolysis from the small jet, and was taken back to the cath lab to dilate with an additional 7cc's in the delivery system balloon.The leak improved, but patient still required multiple plugs to address the pvl.The patient tolerated the procedure well and is stable and recovering.
|
A supplemental mdr is being submitted for correction and additional information.The following sections of this report have been updated: corrected h.6 investigation conclusions and investigation findings.Added new information to h.6 type of investigation.The device was not returned to edwards lifesciences for evaluation.Without the device returned for evaluation, visual inspection, functional testing and dimensional analysis were unable to be completed.Imagery was not provided for review.The complaint was unable to be confirmed as no relevant imagery, and/or medical record was provided.The reported event does not allege a malfunction that could be related to an edwards manufacturing deficiency.A review of the ifu and training manuals revealed no deficiencies.It should be noted that this was an off-label operation as the thv was implanted directly at native mitral valve.The sapien 3 thv (s3) with the commander delivery system (ds) is currently indicated for native aortic valve, surgical or transcatheter bioprosthetic aortic valve, a surgical bioprosthetic mitral valve, or a native mitral valve with an annuloplasty ring replacement.Per the instructions for use (ifu), paravalvular leak (pvl) is a potential adverse event associated with bioprosthetic heart valves.Paravalvular leak refers to blood flowing through a channel between the structure of the implanted valve and the cardiac tissue due toa lack of appropriate sealing of the valve to the target site.Some pvl is not uncommon post deployment.Many cases are mild to moderate, and either resolve over time or do not cause symptoms.Others may be more clinically significant and require intervention.In this case, ''during the procedure of a 29 mm sapien 3 valve in the mitral valve via transfemoral approach, mild pvl was noted.On post-operative day (pod) 14, the patient then developed hemolysis from the small jet, and was taken back to the cath lab to dilate with an additional 7cc's in the delivery system balloon.The leak improved, but patient still required multiple plugs to address the pvl''.In this case, the thv was implanted in the native mitral annulus, which is non-circular in shape.The deployment of the circular thv in a non-circular landing zone can create irregular contact between the thv and landing zone, forming an improper seal leading to paravalvular leak as reported.As such, available information suggests that procedural factors (off-label operation) may have contributed to the complaint event.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.No ifu/labeling/training manual inadequacies were identified.Therefore, no corrective or preventative action nor product risk assessment is required at this time.
|